AC6 Gene Transfer in Patients With Reduced Left Ventricular Ejection Fraction Heart Failure

NCT03360448 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Clinical development plans and strategy for RT-100 being re-evaluated

Conditions

Heart Failure

Interventions

DRUG: Ad5.hAC6
DRUG: Placebo

Sponsor

Renova Therapeutics